TransEnterix Profit Margin

The latest profit margin for TRXC is -1867.47% as of December 2020. That compares with -256.31% in the prior-year period — down 628.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside TransEnterix's historical trend and sector peers before judging valuation or financial health.

Over the past year, TRXC's profit margin moved from -256.31% to -1867.47% — a 628.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TransEnterix's valuation or profitability profile.

Against Healthcare companies, TRXC currently prints -1867.47% for profit margin, while the sector average sits near 13.89%. That is roughly 13541.8% below the sector mean. Large gaps often invite a closer look at TransEnterix's growth, margins, and balance sheet.

Profit Margin shows how effectively TransEnterix converts resources into returns. At -1867.47%, TRXC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -256.31% in the prior-year period — down 628.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TRXC's profit margin (-1867.47%), review year-over-year change from -256.31%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.